The Lancet Oncology in conversation with

207 Episodes

1. Are patient reported outcomes consistent?

   Published: 8/31/2018
2. Changing incidence of adolescent cancer

   Published: 8/31/2018
3. Diffuse intrinsic pontine glioma

   Published: 8/14/2018
4. Detection of residual disease after neoadjuvant chemoradiotherapy for oesophageal cancer

   Published: 6/30/2018
5. Gender and cancer immunotherapy efficacy

   Published: 6/1/2018
6. PROs in regulatory decision making

   Published: 4/25/2018
7. Vulvar field resection

   Published: 3/29/2018
8. Chromatin organisation and cancer prognosis

   Published: 3/1/2018
9. Trial design for brain metastases: The Lancet Oncology: Jan 2018

   Published: 12/30/2017
10. Lung cancer screening: The Lancet Oncology: November 27, 2017

    Published: 11/28/2017
11. Future cancer research priorities in the USA: The Lancet Oncology Commission: October 31, 2017

    Published: 11/1/2017
12. Cancer in Peru: The Lancet Oncology

    Published: 9/28/2017
13. Selective internal radiotherapy for colorectal cancer: The Lancet Oncology: September 2017

    Published: 9/2/2017
14. Indel derived tumour-specific neoantigens: The Lancet Oncology: Aug 2017

    Published: 7/26/2017
15. Prior radiotherapy and pembrolizumab: The Lancet Oncology: June 28, 2017

    Published: 6/29/2017
16. EANO and palliative care: The Lancet Oncology: June 2, 2017

    Published: 6/3/2017
17. Head and neck cancer Series: The Lancet Oncology: April 26, 2017

    Published: 4/26/2017
18. ¹⁸F-FDG PET/CT for multiple myeloma: The Lancet Oncology: April, 2017

    Published: 3/30/2017
19. Response assessment criteria for immunotherapy drugs: The Lancet Oncology: March 2017

    Published: 3/2/2017
20. Genomic modelling for radiation dosage: The Lancet Oncology: Feb 1 2017

    Published: 2/2/2017